CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
DMAC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01556061
NCT01556061Phase 4Completed
CompareCT.gov

Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial

The University of Texas Health Science Center, Houston·interventional·Posted Mar 16, 2012·Updated May 26, 2014

In Brief

A Phase 4 clinical trial evaluating DMAC and CMAC for Obesity. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. This is the first study to investigate the individual and comparative performances of C-MAC and D-MAC in this patient cohort.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 16, 2012
Enrollment StartJun 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.3 years ago

Interventions

DMACdevice

The D blade will constitute the experimental treatment and in a cross over fashion will be tested against CMAC blade

CMACdevice

The CMAC Blade will constitute the active comparator treatment and in a cross over fashion will be tested against D-blade